Target intelligence / Profile preview

AS03 adjuvant (AS03)

Target
AS03
Molecular classification
Other
01

Overview

AS03 is an **oil-in-water emulsion adjuvant** composed of squalene, DL-α-tocopherol (vitamin E), and polysorbate 80. It is not a molecular receptor or protein target but a pharmaceutical excipient designed to stimulate the innate immune system for enhanced vaccine efficacy. AS03 functions primarily by promoting antigen uptake and presentation by antigen-presenting cells and inducing local cytokine production, leading to improved and sustained adaptive immune responses dominated by Th2 polarization and robust memory B cell generation. Key mechanisms involve activation of NLRP3 and TLR signaling (with some pathway independence), modulation of chemokine/cytokine expression, and induction of ER stress responses in myeloid cells, ultimately driving enhanced antibody responses and the recruitment of immune effector cells. AS03 is licensed and widely used in pandemic influenza vaccines and increasingly investigated in emerging infectious disease vaccines, demonstrating good safety and immunogenicity profiles in clinical and preclinical studies [1][2][3][4][5][6]. **Note:** The query "Innate immune system stimulation via AS03 adjuvant" refers to a process or mechanism, not a canonical molecular target. AS03 is an adjuvant system, not a discrete receptor, enzyme, or classical therapeutic target. The correct way to structure information for later use is to list AS03 as an adjuvant excipient that acts on multiple innate immune pathways, not as a molecular target itself.

Other names
AS03AS03 adjuvantoil-in-water emulsion adjuvant (with alpha-tocopherol, squalene, polysorbate 80)
02

Mechanism of action

Facilitates antigen uptake and presentation by antigen-presenting cells (APCs) [1][2][3] Activates innate immune pathways (NLRP3 and TLR-pathways, with unique independence from ASC and MyD88) [2][3] Induces cytokine and chemokine secretion (e.g., IL-6, CCL2, CCL3, CXCL1) recruiting granulocytes and modulating adaptive and innate responses [2][3][6] Triggers ER stress and activates IRE1α/JNK signaling in myeloid cells (impacts T follicular helper cell response and antibody quality) [5]

03

Biological functions

Immune response enhancementActivation of innate immune systemAugmentation of antigen presentationActivation of cytokine production
04

Disease associations

Infection (used in vaccines for influenza, SARS-CoV-2, H5N1)Other (prevention of infectious diseases via vaccination)
05

Safety considerations

Generally well-tolerated; clinical trials report favorable safety [1][2][6]Local reactogenicity (injection site reactions)Ongoing monitoring for rare immunopathology (data primarily indicate good safety but vigilance in pandemic scenarios recommended) [1][3][6]
06

Interacting drugs

Influenza vaccines (e.g., Pandemrix, GSK's H5N1 pandemic vaccine, plant-based SARS-CoV-2 VLP vaccine)
07

Biomarkers

IL-6CCL2CCL3CXCL1CD4+ T cell responseAntigen-specific memory B cell frequency and breadth

Beyond the preview

Go deeper on AS03 adjuvant (AS03).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AS03 adjuvant (AS03).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call